BackKinarus Therapeutics Holding AG Overview
Kinarus Therapeutics Holding AG

Kinarus Therapeutics Holding AG PEG Ratio

Latest PEG ratio for Kinarus Therapeutics Holding AG: -663.52 — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

PEG Ratio

-663.52

PEG Ratio

-663.52

The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.

PEG Ratio (Comparison Companies)

Loading

PEG Ratio History

Loading

PEG Ratio Comparison

Loading

Kinarus Therapeutics Holding AG (PRFN.SW) FAQ

The latest PEG ratio for PRFN.SW is -663.52. That is below the sector sector average of 10.05. Investors often review this figure alongside Kinarus Therapeutics Holding AG's historical trend and sector peers before judging valuation or financial health.

Against its sector companies, PRFN.SW currently prints -663.52 for PEG ratio, while the sector average sits near 10.05. That is roughly 6699.0% below the sector mean. Large gaps often invite a closer look at Kinarus Therapeutics Holding AG's growth, margins, and balance sheet.

A PEG ratio of -663.52 for Kinarus Therapeutics Holding AG is not 'good' or 'bad' on its own. Compare it with the peer average (10.05) and with PRFN.SW's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.

After noting PRFN.SW's PEG ratio (-663.52), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.